Nitric oxide and pulmonary hypertension.

Area of Science:

• Cardiovascular Medicine
• Pulmonary Medicine
• Vascular Biology

Background:

• Pulmonary hypertension (PH) is a severe complication of lung and heart diseases, marked by vascular remodeling and reduced vascular tone.
• Nitric oxide (NO) plays a dual role, modulating vascular injury but also producing cytotoxic radicals.
• The balance of NO and reactive radicals dictates its protective versus adverse effects in PH.

Purpose of the Study:

• To explore the role of nitric oxide in pulmonary hypertension.
• To review the clinical efficacy of nitric oxide and novel therapeutics for PH.

Main Methods:

• Literature review of nitric oxide's effects in pulmonary hypertension.
• Analysis of clinical outcomes in patients treated with nitric oxide and other agents.

Main Results:

• Nitric oxide demonstrates clinical effectiveness in specific PH cases, including congenital heart disease, mitral valvular disease, and post-cardiac transplantation.
• Newer therapies like phosphodiesterase inhibitors, natriuretic peptides, and aqueous nitric oxide show promise in managing elevated pulmonary vascular resistance.

Conclusions:

• Nitric oxide's therapeutic utility in pulmonary hypertension is established, contingent on balancing its beneficial and detrimental effects.
• Emerging treatments offer additional strategies for managing elevated pulmonary vascular resistance in pulmonary hypertension.